Software-based analysis of 1-hour Holter ECG to select for prolonged ECG monitoring after stroke
- PMID: 32862499
- PMCID: PMC7545589
- DOI: 10.1002/acn3.51157
Software-based analysis of 1-hour Holter ECG to select for prolonged ECG monitoring after stroke
Abstract
Objective: Identification of ischemic stroke patients at high risk for paroxysmal atrial fibrillation (pAF) during 72 hours Holter ECG might be useful to individualize the allocation of prolonged ECG monitoring times, currently not routinely applied in clinical practice.
Methods: In a prospective multicenter study, the first analysable hour of raw ECG data from prolonged 72 hours Holter ECG monitoring in 1031 patients with acute ischemic stroke/TIA presenting in sinus rhythm was classified by an automated software (AA) into "no risk of AF" or "risk of AF" and compared to clinical variables to predict AF during 72 hours Holter-ECG.
Results: pAF was diagnosed in 54 patients (5.2%; mean age: 78 years; female 56%) and was more frequently detected after 72 hours in patients classified by AA as "risk of AF" (n = 21, 17.8%) compared to "no risk of AF" (n = 33, 3.6%). AA-based risk stratification as "risk of AF" remained in the prediction model for pAF detection during 72 hours Holter ECG (OR3.814, 95% CI 2.024-7.816, P < 0.001), in addition to age (OR1.052, 95% CI 1.021-1.084, P = 0.001), NIHSS (OR 1.087, 95% CI 1.023-1.154, P = 0.007) and prior treatment with thrombolysis (OR2.639, 95% CI 1.313-5.306, P = 0.006). Similarly, risk stratification by AA significantly increased the area under the receiver operating characteristic curve (AUC) for prediction of pAF detection compared to a purely clinical risk score (AS5F alone: AUC 0.751; 95% CI 0.724-0.778; AUC for the combination: 0.789, 95% CI 0.763-0.814; difference between the AUC P = 0.022).
Interpretation: Automated software-based ECG risk stratification selects patients with high risk of AF during 72 hours Holter ECG and adds predictive value to common clinical risk factors for AF prediction.
© 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Conflict of interest statement
TU reports personal fees from Merck Serono and Pfizer, grants from Else Kröner‐Fresenius Stiftung. RW reports having been an investigator or consultant for, or received fees from Bayer, Berlin Chemie, Bristol‐Myers‐ Squibb, Boehringer Ingelheim, CVRx, Daiichi Sankyo, Gilead, Johnson & Johnson, Medtronic, Novartis, Pfizer, Sanofi, Servier since 2003. He received research grants from Boehringer Ingelheim, European Union and Bundesministerium für Bildung und Forschung (BMBF). KG reports personal fees and/or non‐financial support from Bayer, Boehringer Ingelheim, Bristol‐Meyers Squibb, Daiichi Sankyo and Pfizer. SG, BL, KW and MH report no disclosures.
Figures


References
-
- McGrath ER, Kapral MK, Fang J, et al. Association of atrial fibrillation with mortality and disability after ischemic stroke. Neurology 2013;81(9):825–832. - PubMed
-
- Wachter R, Gröschel K, Gelbrich G, et al. Holter‐electrocardiogram‐monitoring in patients with acute ischaemic stroke (Find‐AFRANDOMISED): an open‐label randomised controlled trial. Lancet Neurol 2017;16(4):282–290. - PubMed
-
- Edwards JD, Kapral MK, Fang J, et al; Investigators of the Registry of the Canadian Stroke N . Underutilization of ambulatory ECG monitoring after stroke and transient ischemic attack: missed opportunities for atrial fibrillation detection. Stroke 2016;47(8):1982–1989. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical